Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ad M Kamper"'
Autor:
Roy Looman, Harmke A Polinder-Bos, Marielle H. Emmelot-Vonk, Esther M.M. van de Glind, Esther J. M. de Brouwer, Huub A.A.M. Maas, Jeannet C Bos, Ralph Vreeswijk, Barbara C. van Munster, Laura C. Blomaard, Linda M Kampschreur, Jessica M. van der Bol, Steffy W. Jansen, Liesbeth Hempenius, Hanna C. Willems, Marjolein A. Wijngaarden, Anke J Borgers, Jan Festen, Petra E. Spies, Dennis G Barten, Aisha M Salarbaks, Rosalinde A L Smits, Ad M Kamper, Cees van Nieuwkoop, Sarah H M Robben, Marlies E M Regtuijt, Geert Labots, Frederiek van den Bos, Raya E S Geels, Carolien M. J. van der Linden, Francesco U.S. Mattace-Raso, Henrike J. Schouten, Marre M M de Koning, Bas de Groot, Leanne B L E Oosterwijk, Simon P. Mooijaart, Jacinta A. Lucke, Caroline E. Wyers, Rikje Ruiter, Rachida el Moussaoui, Oscar J. de Vries, Suzanne C. van Dijk, Floor J. van Deudekom, Orla M Smit
Publikováno v:
Age and Ageing
Age and Ageing, 50(3), 631-640. Oxford University Press
Age and ageing, 50(3), 631-640. Oxford University Press
Age and Ageing, 50(3), 631-640. Oxford UP
Age and Ageing, 50(3), 631-640. Oxford University Press
Age and ageing, 50(3), 631-640. Oxford University Press
Age and Ageing, 50(3), 631-640. Oxford UP
Background During the first wave of the coronavirus disease 2019 (COVID-19) pandemic, older patients had an increased risk of hospitalisation and death. Reports on the association of frailty with poor outcome have been conflicting. Objective The aim
Autor:
Edmée J M Schrijver, Anne M Lagaay, Mark H.H. Kramer, Pierre M. Bet, Sabine H.A. Diepeveen, Leo Boelaarts, Prabath W. B. Nanayakkara, Peter M. van de Ven, Oscar J. de Vries, Frank W. Bloemers, Astrid M van Strien, Rob J. van Marum, Sander Anten, Ad M Kamper
Publikováno v:
Schrijver, E J M, De Vries, O J, Van De Ven, P M, Bet, P M, Kamper, A M, Diepeveen, S H A, Van Marum, R J, Van Strien, A M, Anten, S, Lagaay, A M, Boelaarts, L, Bloemers, F W, Kramer, M H H & Nanayakkara, P W B 2018, ' Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients : A multi-centre double-blind randomised controlled clinical trial ', Age and Ageing, vol. 47, no. 1, pp. 48-55 . https://doi.org/10.1093/ageing/afx124
Age and Ageing, 47(1), 48-55. Oxford University Press
Age and Ageing, 47(1), 48-55. Oxford University Press
Background: because the few randomised placebo-controlled trials investigating the potential role for prophylactic haloperidol in delirium prevention have focused on specific surgical populations, we investigated its efficacy and safety in acutely ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb35962f9c9321b008d6db22570a9eb
https://research.vumc.nl/en/publications/fa60d21d-5e9b-4f4a-9792-9e606da4eeff
https://research.vumc.nl/en/publications/fa60d21d-5e9b-4f4a-9792-9e606da4eeff
Autor:
Esther Kuipéri, Oscar J. de Vries, Astrid Verburg, Ad M Kamper, Pierre M. Bet, Karola de Graaf, Edmée J M Schrijver, Douwe Pons, Anne M Lagaay, Andrea Siegel, Sabine H.A. Diepeveen, Leo Boelaarts, Rob J. van Marum, Astrid M van Strien, Prabath W. B. Nanayakkara, Sander Anten, Peter M. van de Ven, Mark H. H. Kramer
Publikováno v:
Schrijver, E J M, de Vries, O J, Verburg, A, de Graaf, K, Bet, P M, van de Ven, P M, Kamper, A M, Diepeveen, S H A, Anten, S, Siegel, A, Kuiperi, E, Lagaay, A M, van Marum, R J, van Strien, A M, Boelaarts, L, Pons, D, Kramer, M H H & Nanayakkara, P W B 2014, ' Efficacy and safety of haloperidol prophylaxis for delirium prevention in older medical and surgical at-risk patients acutely admitted to hospital through the emergency department: study protocol of a multicenter, randomised, double-blind, placebo-controlled clinical trial ', BMC Geriatrics, vol. 14, 96 . https://doi.org/10.1186/1471-2318-14-96
BMC Geriatrics, 14:96. BioMed Central
BMC Geriatrics
BMC Geriatrics, 14:96. BioMed Central
BMC Geriatrics
Background Delirium is associated with substantial morbidity and mortality rates in elderly hospitalised patients, and a growing problem due to increase in life expectancy. Implementation of standardised non-pharmacological delirium prevention strate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb757d8b3195bd0bec5fdccbec8e1d0
https://research.vumc.nl/en/publications/822191a3-eb31-4e35-99bd-a766a0b1bd8c
https://research.vumc.nl/en/publications/822191a3-eb31-4e35-99bd-a766a0b1bd8c
Autor:
Coen D.A. Stehouwer, Rob A.J.M. Van Dijk, Frank Stam, Erik H. Serné, Miranda T. Schram, Casper G. Schalkwijk, Ad M Kamper, Prabath W. B. Nanayakkara, Renate T. de Jongh, Peter G. Scheffer, Greetje de Vries, Maarten E. Tushuizen, Deva Lampe
Publikováno v:
Schram, M T, Stam, F, De Jongh, R T, De Vries, G D, Van Dijk, R A J M, Serné, E H, Lampe, D, Nanayakkara, P W B, Tushuizen, M E, Scheffer, P G, Schalkwijk, C G, Kamper, A M & Stehouwer, C D A 2003, ' The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers : A placebo-controlled randomised clinical trial ', Atherosclerosis, vol. 170, no. 1, pp. 59-72 . https://doi.org/10.1016/S0021-9150(03)00231-4
Atherosclerosis, 170(1), 59-72. Elsevier Ireland Ltd
Atherosclerosis, 170(1), 59-72. Elsevier Ireland Ltd
This randomised double-blind, placebo-controlled, clinical trial investigated the effect of 3 months of treatment with calcium dobesilate on endothelium-dependent vasodilation, markers of endothelial function, blood pressure, and markers of oxidation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0eb0a4c4879e8949d5d56618605c7ca
https://research.vumc.nl/en/publications/74c00338-5f82-45df-93b4-2a5135a0df1d
https://research.vumc.nl/en/publications/74c00338-5f82-45df-93b4-2a5135a0df1d
Autor:
Iris J. A. M. Jonkers, Augustinus H. M. Smelt, Frits H.A.F. de Man, Marijke Frölich, Jan A. Gevers Leuven, Gerard J. Blauw, Arnoud van der Laarse, Ad M. Kamper
Publikováno v:
Journal of hypertension. 19(4)
In hypertriglyceridemic patients, hypertension occurs frequently and may be associated with hyperinsulinemia and elevated plasma levels of free fatty acids (FFA). Besides the lipid-lowering effects, fibrates have been shown to reduce blood pressure i